Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla.

Alterations in renal prostaglandins (PGs) may contribute to some of the renal manifestations in diabetes leading to nephropathy. PG production is dependent on the activity of cyclooxygenases (COX-1 AND -2) and PG synthases. Our present study investigated levels of these enzymes in streptozotocin-diabetic rats at 2, 4, 6, and 8 wk of diabetes. Immunohistochemical analysis revealed an increase in COX signal in the inner and outer medulla of diabetic rats. This was confirmed by Western blotting, showing up to a fourfold increase in both COX isoforms at 4-6 wk of diabetes. Also, Western blot analysis revealed a sixfold increase in PGE2 synthase expression in the outer medullary region of 6-wk diabetic rats but no difference in the inner medulla. In cultured rat inner medullary collecting duct (IMCD), levels of COX were increased two- to threefold in cells exposed for 4 days to 37.5 mM glucose compared with control of 17.5 mM. While no change in PGE2 synthase levels was noted, PGE2 synthesis was increased. Furthermore, levels of EP1 and EP4 mRNA were increased, as well as a twofold increase in EP4 protein levels. Future studies will determine which COX isoform is contributing to the majority of PGE2 produced in the diabetic IMCD and the significance of these findings to disturbances in IMCD function and to the progression of diabetic nephropathy.

[1]  K. Nakao,et al.  Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist. , 2002, Journal of the American Society of Nephrology : JASN.

[2]  T. Tanabe,et al.  Prostacyclin-dependent Apoptosis Mediated by PPARδ* , 2001, The Journal of Biological Chemistry.

[3]  E. Schulze-Lohoff,et al.  Regulation of mesangial cell function by vasodilatory signaling molecules. , 2001, Cardiovascular research.

[4]  Rania Nasrallah,et al.  Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells. , 2001, American journal of physiology. Renal physiology.

[5]  S. Mader,et al.  Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. , 2001, The Journal of clinical investigation.

[6]  Rania Nasrallah,et al.  Molecular and biochemical characterization of prostacyclin receptors in rat kidney. , 2001, American journal of physiology. Renal physiology.

[7]  C. Hao,et al.  Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. , 2000, The Journal of clinical investigation.

[8]  R. Harris,et al.  Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. , 2000, The Journal of clinical investigation.

[9]  J. Kopple,et al.  Protein metabolism in patients with chronic renal failure: role of uremia and dialysis. , 2000, Kidney international.

[10]  O. Laneuville,et al.  NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line. , 1999, Journal of the American Society of Nephrology : JASN.

[11]  B. Escalante,et al.  Effect of cyclooxygenase-2 inhibition on renal function after renal ablation. , 1999, Hypertension.

[12]  H. Seyberth,et al.  Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. , 1999, Journal of the American Society of Nephrology : JASN.

[13]  S. Narumiya,et al.  Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions. , 1999, Kidney international.

[14]  M. Burnier,et al.  Renal effects of selective cyclooxygenase‐2 inhibition in normotensive salt‐depleted subjects , 1999, Clinical pharmacology and therapeutics.

[15]  K. Thai,et al.  Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli. , 1999, Kidney international.

[16]  G. Almazan,et al.  Localization of Functional Prostaglandin E2 Receptors EP3 and EP4 in the Nuclear Envelope* , 1999, The Journal of Biological Chemistry.

[17]  D. Dewitt,et al.  Cox-2-selective inhibitors: the new super aspirins. , 1999, Molecular pharmacology.

[18]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[19]  M. Abramovitz,et al.  Nuclear localization of prostaglandin E2 receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Hébert,et al.  Prostanoid signaling, localization, and expression of IP receptors in rat thick ascending limb cells. , 1998, American journal of physiology. Renal physiology.

[21]  B. Koller,et al.  Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. , 1998, American journal of physiology. Renal physiology.

[22]  R. Breyer,et al.  Regulation of renal function by prostaglandin E receptors. , 1998, Kidney international. Supplement.

[23]  R. DuBois,et al.  Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. , 1997, The American journal of physiology.

[24]  K Watanabe,et al.  Two types of microsomal prostaglandin E synthase: glutathione-dependent and -independent prostaglandin E synthases. , 1997, Biochemical and biophysical research communications.

[25]  H. Seyberth,et al.  Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. , 1997, The American journal of physiology.

[26]  L. Ruilope,et al.  Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy. , 1997, American journal of hypertension.

[27]  M. Schwartz,et al.  Diabetes Complications--Why Is Glucose Potentially Toxic? , 1996, Science.

[28]  H. Jacobson,et al.  Differential localization of prostaglandin E receptor subtypes in human kidney. , 1996, The American journal of physiology.

[29]  J. Pfeilschifter,et al.  Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells. , 1996, The Biochemical journal.

[30]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[31]  Hyung-Suk Kim,et al.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.

[32]  H. Jacobson,et al.  Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. , 1994, The Journal of clinical investigation.

[33]  S. Narumiya,et al.  VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes , 1994 .

[34]  R. Shigemoto,et al.  Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. , 1994, The American journal of physiology.

[35]  F. DeRubertis,et al.  Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  J. Manivel,et al.  Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. , 1992, Kidney international.

[37]  W. K. Sonnenburg,et al.  A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells. , 1990, The Journal of biological chemistry.

[38]  G. Remuzzi,et al.  Glomerular Hyperfiltration and Urinary Prostaglandins in Type 1 Diabetes Mellitus , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[39]  F. Pugliese,et al.  Renal Hemodynamics and Urinary Excretion of 6-Keto-Prostaglandin F1α and Thromboxane B2 in Newly Diagnosed Type I Diabetic Patients , 1988, Diabetes.

[40]  N. Farman,et al.  Segmental synthesis and actions of prostaglandins along the nephron. , 1987, The American journal of physiology.

[41]  M. Schambelan,et al.  Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. , 1985, The Journal of clinical investigation.

[42]  J. Kreisberg,et al.  The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells. , 1983, Prostaglandins, leukotrienes, and medicine.

[43]  M. Dunn,et al.  Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin. , 1983, The Journal of clinical investigation.

[44]  W. Smith,et al.  Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. , 1978, The American journal of physiology.

[45]  V. Devita,et al.  Clinical antitumor activity and toxicity of streptozotocin (NSC‐85998) , 1974, Cancer.

[46]  D. Dewitt,et al.  Prostaglandin endoperoxide H synthases-1 and -2. , 1996, Advances in immunology.

[47]  H. Schramek,et al.  ET‐1 and PDGF BB Induce MEK mRNA and Protein Expression in Mesangial Cells , 1995, Journal of cardiovascular pharmacology.

[48]  T. Ogihara,et al.  Effects of beraprost sodium, a stable analogue of prostacyclin, on hyperplasia, hypertrophy and glycosaminoglycan synthesis of rat aortic smooth muscle cells. , 1993, Artery.